With $125M More in Financing, Inscripta Ramps Up Expansion

Inscripta plans to expand the capabilities of its Onyx™ Digital Genome Engineering platform beyond microbes, to include the ability to support mammalian cells including humans, CEO Kevin Ness tells GEN Edge.

Read the full article here

Related Articles